Literature DB >> 25394973

[Avoiding pitfalls in the diagnostics of bone neoplasms: importance of reference pathology].

M Werner1.   

Abstract

Bone tumors account for only approximately 1% of the total number of malignant tumors in humans so that they are only rarely diagnosed and appropriate experience is difficult to acquire. Although the number of entities is limited there exist very different clinical and radiological images depending on the manifestation in the different regions of the skeleton. Bone tumors are also histologically structured very differently even within a particular entity. Prior to the histopathological diagnosis the location of the lesion within the entire skeleton and in relation to the tumor-bearing bone must be clarified based on imaging findings, i.e. which bone is affected, which portion of the bone is affected and is the tumor centrally located in the marrow cavity, in the area of the corticalis or on the outside? It is known that bone tumors show diagnostically relevant preferential locations in both the total skeleton as well as within the affected bone depending on the entity and that the age of onset also varies. In this article the most common reasons for errors in assessment are discussed. In most cases it is possible for reference pathology to still correctly classify specific cases by a consistent consideration of diagnostic radiology in combination with morphology. Although diagnostic progress for specific entities of bone tumors has been achieved using molecular methods, the established principle of interdisciplinary cooperation is the prerequisite for the correct diagnosis of these tumors. The therapeutic consequences for patients can be substantial and result in life-long functional limitations depending on the diagnosis (e.g. joint resection for osteosarcoma in childhood and adolescence). A correct diagnosis is therefore of great importance for far-reaching therapeutic decision-making.

Entities:  

Mesh:

Year:  2014        PMID: 25394973     DOI: 10.1007/s00292-014-2012-1

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  12 in total

1.  The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.

Authors:  D Andreou; S S Bielack; D Carrle; M Kevric; R Kotz; W Winkelmann; G Jundt; M Werner; S Fehlberg; L Kager; T Kühne; S Lang; M Dominkus; G U Exner; J Hardes; A Hillmann; V Ewerbeck; U Heise; P Reichardt; P-U Tunn
Journal:  Ann Oncol       Date:  2010-10-28       Impact factor: 32.976

2.  Determining growth rates of focal lesions of bone from radiographs.

Authors:  G S Lodwick; A J Wilson; C Farrell; P Virtama; F Dittrich
Journal:  Radiology       Date:  1980-03       Impact factor: 11.105

3.  Molecular diagnosis in Ewing family tumors: the Rizzoli experience--222 consecutive cases in four years.

Authors:  Gabriella Gamberi; Stefania Cocchi; Stefania Benini; Giovanna Magagnoli; Luca Morandi; Jennifer Kreshak; Marco Gambarotti; Piero Picci; Licciana Zanella; Marco Alberghini
Journal:  J Mol Diagn       Date:  2011-03-31       Impact factor: 5.568

4.  USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts.

Authors:  Andre M Oliveira; Antonio R Perez-Atayde; Carrie Y Inwards; Fabiola Medeiros; Victoria Derr; Bae-Li Hsi; Mark C Gebhardt; Andrew E Rosenberg; Jonathan A Fletcher
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

5.  Molecular diagnosis of Ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR.

Authors:  Isidro Machado; Rosa Noguera; Antonio Pellin; Jose A Lopez-Guerrero; Marta Piqueras; Samuel Navarro; Antonio Llombart-Bosch
Journal:  Diagn Mol Pathol       Date:  2009-12

6.  USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis.

Authors:  André M Oliveira; Margaret M Chou
Journal:  Hum Pathol       Date:  2013-06-12       Impact factor: 3.466

7.  Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.

Authors:  Sam Behjati; Patrick S Tarpey; Nadège Presneau; Susanne Scheipl; Nischalan Pillay; Peter Van Loo; David C Wedge; Susanna L Cooke; Gunes Gundem; Helen Davies; Serena Nik-Zainal; Sancha Martin; Stuart McLaren; Victoria Goodie; Ben Robinson; Adam Butler; Jon W Teague; Dina Halai; Bhavisha Khatri; Ola Myklebost; Daniel Baumhoer; Gernot Jundt; Rifat Hamoudi; Roberto Tirabosco; M Fernanda Amary; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Adrienne M Flanagan
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

8.  The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks.

Authors:  M Riminucci; B Liu; A Corsi; A Shenker; A M Spiegel; P G Robey; P Bianco
Journal:  J Pathol       Date:  1999-01       Impact factor: 7.996

9.  IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.

Authors:  M Fernanda Amary; Krisztian Bacsi; Francesca Maggiani; Stephen Damato; Dina Halai; Fitim Berisha; Robin Pollock; Paul O'Donnell; Anita Grigoriadis; Tim Diss; Malihe Eskandarpour; Nadège Presneau; Pancras Cw Hogendoorn; Andrew Futreal; Roberto Tirabosco; Adrienne M Flanagan
Journal:  J Pathol       Date:  2011-05-19       Impact factor: 9.883

10.  Molecular distinction of chondrosarcoma from chondroblastic osteosarcoma through IDH1/2 mutations.

Authors:  Darcy A Kerr; Hector U Lopez; Vikram Deshpande; Francis J Hornicek; Zhenfeng Duan; Yaxia Zhang; Andrew E Rosenberg; Darrel R Borger; G Petur Nielsen
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.298

View more
  1 in total

1.  Clinical Routine and Necessary Advances in Soft Tissue Tumor Imaging Based on the ESSR Guideline: Initial Findings.

Authors:  Alexander Korthaus; Sebastian Weiss; Alexej Barg; Johannes Salamon; Carsten Schlickewei; Karl-Heinz Frosch; Matthias Priemel
Journal:  Tomography       Date:  2022-06-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.